发明名称 agente para o tratamento ou prevenção de doenças associadas com a atividade de fatores neurotróficos.
摘要 A compound depicted by the formula below, or a pharmaceutically acceptable salt or solvate thereof. wherein, R 1 represents (1) a C 3-6 alkyl group,(2) a C 1-6 alkyl group substituted with one or more substituent group(s) selected from those consisting a halogen atom, etc., (3) a C 3-10 non-aromatic cyclic hydrocarbon group or a 5- to 6-membered non-aromatic heterocyclic group which respectively is optionally substituted with one or more substituent group(s) selected from those consisting an oxo group, etc., (4) an aromatic cyclic hydrocarbon group substituted with one or more substituent selected from the group consisting halogen atom and C 1-4 alkoxy group; X represents NH, O, or S; Y represents CH or N; Z represents N or a C-R 2 ; R 2 represents (1) hydrogen atom, (2) a C 1-6 alkyl group, a C 2-6 alkenyl group or a C 2-6 alkynyl group that respectively is optionally substituted with one or more substituent group(s) selected from among those consisting (a) a halogen atom, etc., or (3) a C 5-6 non-aromatic cyclic hydrocarbon group or a 5- to 6-membered non-aromatic heterocyclic group optionally substituted; ring A represents a benzene ring optionally substituted; ring B represents a benzene ring optionally substituted.
申请公布号 BRPI1011961(A2) 申请公布日期 2016.04.26
申请号 BR2010PI11961 申请日期 2010.05.28
申请人 SUMITOMO CHEMICAL COMPANY, LIMITED 发明人 JUNICHI ISHIKAWA;KENTARO KOBAYASHI;KOICHI SAITO;NORIHISA OHE
分类号 C07D405/14;A61K31/4184;A61K31/423;A61K31/428;A61K31/4439;A61K31/454;A61P1/02;A61P1/04;A61P3/10;A61P7/02;A61P7/04;A61P9/08;A61P9/10;A61P13/12;A61P19/02;A61P19/08;A61P19/10;A61P21/02;A61P25/00;A61P25/02;A61P25/04;A61P25/08;A61P25/14;A61P25/16;A61P25/18;A61P25/22;A61P25/24;A61P25/28;A61P27/02;A61P27/06;A61P27/16;A61P29/00;A61P43/00;C07D409/14;C07D413/04;C07D413/14;C07D417/04;C07D417/14 主分类号 C07D405/14
代理机构 代理人
主权项
地址